🇺🇸 United States Country × Condition
heart failure Clinical Trials in United States
Active clinical trials for heart failure with research sites in United States. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 24 // Recruiting: 24 Phases: Phase 2, EARLY_Phase 1 // Updated: Daily
Total Trials
24
Recruiting Now
24
Country
🇺🇸 United States
Active Trials in United States (24)
NCT06174103
Recruiting
BiVACOR® Total Artificial Heart Early Feasibility Study
Enrollment
20 pts
Country
🇺🇸 United States
BiVACOR Inc.
View Trial → NCT07337577
Recruiting
Targeted Artificial Intelligence Language mOdel Recommendations for Heart Failure (TAILOR-HF)
Enrollment
500 pts
Country
🇺🇸 United States
Brigham and Women's Hospital
View Trial → NCT06130059 Phase 2
Recruiting
Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation
Enrollment
60 pts
Country
🇺🇸 United States
University of Texas Southwestern Me...
View Trial → NCT07870395
Recruiting
Voice-based Outcome Identification and Clinical Evaluation in Heart Failure
Enrollment
450 pts
Country
🇺🇸 United States
Noah Labs
View Trial → NCT06933875
Recruiting
Promoting Palliative Care for People With Heart Failure
Enrollment
2,260 pts
Country
🇺🇸 United States
Yale University
View Trial → NCT06118983
Recruiting
Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF)
Enrollment
1,094 pts
Country
🇺🇸 United States
Weill Medical College of Cornell Un...
View Trial → NCT05700617 EARLY_Phase 1
Recruiting
Cardiac Power Output in Cardiogenic Shock Patients
Enrollment
5 pts
Country
🇺🇸 United States
University of Chicago
View Trial → NCT07547540 Phase 1
Recruiting
A Study of LY3971297 in Participants With Heart Failure
Enrollment
90 pts
Country
🇺🇸 United States
Eli Lilly and Company
View Trial → NCT06736574 Phase 3
Recruiting
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Enrollment
1,800 pts
Country
🇺🇸 United States
Cytokinetics
View Trial → NCT07349797
Recruiting
MediBeacon® Transdermal GFR System for the Evaluation of Kidney Function in Adults With Heart Failure
Enrollment
15 pts
Country
🇺🇸 United States
MediBeacon
View Trial → NCT04829617
Recruiting
Promoting Well-being and Health in Heart Failure
Enrollment
280 pts
Country
🇺🇸 United States
Massachusetts General Hospital
View Trial → NCT06425848
Recruiting
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
Enrollment
2,000 pts
Country
🇺🇸 United States
University of Kansas Medical Center
View Trial → NCT07145138
Recruiting
UIC Multi-Ethnic DCM Registry
Enrollment
1,500 pts
Country
🇺🇸 United States
University of Illinois Chicago
View Trial → NCT07574593
Recruiting
NORM-HF Pivotal Study
Enrollment
800 pts
Country
🇺🇸 United States
Foundry Innovation & Research 1, Li...
View Trial → NCT06965504
Recruiting
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery
Enrollment
250 pts
Country
🇺🇸 United States
Abiomed Inc.
View Trial → NCT06779552
Recruiting
CardioMEMS HF System Coverage With Evidence Development Study
Enrollment
1,000 pts
Country
🇺🇸 United States
Abbott Medical Devices
View Trial → NCT05919342
Recruiting
Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"
Enrollment
3,904 pts
Country
🇺🇸 United States
NHS Greater Glasgow and Clyde
View Trial → NCT06049420
Recruiting
Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients
Enrollment
95 pts
Country
🇺🇸 United States
West Virginia School of Osteopathic...
View Trial → NCT06849752
Recruiting
Early Assessment and Initiation of GuideLine-Directed Evidence-Based Management-HF
Enrollment
1,000 pts
Country
🇺🇸 United States
The Cleveland Clinic
View Trial → NCT06195059
Recruiting
Contrast Echocardiography During Exercise to Assess Pulmonary Blood Volume
Enrollment
800 pts
Country
🇺🇸 United States
Mayo Clinic
View Trial → NCT06070428
Recruiting
Project 4: ACHIEVE PATHFINDER
Enrollment
400 pts
Country
🇺🇸 United States
Henry Ford Health System
View Trial → NCT02966665 Phase 1
Recruiting
: Vascular Function in Health and Disease
Enrollment
420 pts
Country
🇺🇸 United States
D. Walter Wray
View Trial → NCT06424288 Phase 3
Recruiting
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Enrollment
6,712 pts
Country
🇺🇸 United States
Boehringer Ingelheim
View Trial → NCT07232030
Recruiting
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
Enrollment
2,500 pts
Country
🇺🇸 United States
CVRx, Inc.
View Trial → Frequently Asked Questions
How many heart failure clinical trials are active in United States?
There are currently 24 active clinical trials for heart failure with sites in United States, of which 24 are actively recruiting patients.
How can I join a heart failure clinical trial in United States?
To join a heart failure clinical trial in United States, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in United States directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are heart failure trials in United States?
Active heart failure trials in United States span Phase 2, EARLY_Phase 1, Phase 1, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology